EVO101

TypeTopical StagePhase 2 Latest updateMar 5, 2025Phase 2 results posted

Results

Trial: NCT05579899

Percent Change in EASI From Baseline to Week 8After 8 weeks

Lower scores mean less severe eczema.

Vehicle Cream59 people

62% lower

EVO101 Cream60 people

44% lower

040%80%

NCT05579899 · Ages 18+ · Results posted Mar 2025 · This is a summary of trial data for informational purposes only. It is not medical advice.

What is EASI?

EASI stands for Eczema Area and Severity Index.
EASI assesses the extent and severity of atopic dermatitis. EASI is a composite index with scores ranging from 0 to 72. Higher values indicate more severe or extensive disease.As this trial registered it · NCT05579899

Why this trial?

EVO101 has one trial with posted results, and NCT05579899 compared the drug with placebo on a result this page charts.

History

Earliest recorded event: Sep 27, 2022. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

Mar 5, 2025Phase 2 results postedSafety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis ClinicalTrials.gov NCT05579899
Jul 27, 2023Phase 2 trial completedSafety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis ClinicalTrials.gov NCT05579899
Sep 27, 2022Phase 2 trial startedSafety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis ClinicalTrials.gov NCT05579899

Sources

Trials

NCT05579899Protocol (May 11, 2023) · Analysis plan (Aug 17, 2023)